chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Recurrent erythema multiforme x 3 since February 2022 with cutaneous and oral presentation; Recurrent erythema multiforme x 3 since February 2022 with cutaneous and oral presentation; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Nov2021 at 13:00 as dose 3 (booster), single (Lot number: FH8027) at the age of 44 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic Arthritis" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Bronchitis" (unspecified if ongoing); "Pneumonia" (unspecified if ongoing); "bilateral TKR" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: HUMIRA; NAPROXEN; EXCEDRIN MIGRAINE. Past drug history included: Plaquenil for Allergy; Pitted fruits for Allergy; Raw almonds for Allergy. Vaccination history included: BNT162b2 (Prev dose Product=COVID 19,, Prev dose brand=Pfizer,, Prev dose brand unknown=False,, Prev dose lot number=EK573P,, Prev dose lot unknown=False,, Prev dose administration date=23Dec2020,, Prev dose administration time=08:30 am, Prev dose dose number=1,, Prev dose vaccine location=Right arm), administration date: 23Dec2020, when the patient was 42-year-old, for COVID-19 immunization, reaction(s): "COVID-19"; BNT162b2 (Prev dose Product=COVID 19,, Prev dose brand=Pfizer,, Prev dose brand unknown=False,, Prev dose lot number=EL3264,, Prev dose lot unknown=False,, Prev dose administration date=13Jan2021,, Prev dose administration time=09:00 am, Prev dose dose number=2,, Prev dose vaccine location=Right arm,), administration date: 13Jan2021, when the patient was 43-year-old, for COVID-19 immunization, reaction(s): "COVID-19". The following information was reported: ERYTHEMA MULTIFORME (medically significant), DISEASE RECURRENCE (non-serious) all with onset 02Feb2022 at 14:00, outcome "not recovered" and all described as "Recurrent erythema multiforme x 3 since February 2022 with cutaneous and oral presentation". The events "recurrent erythema multiforme x 3 since february 2022 with cutaneous and oral presentation" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of erythema multiforme, disease recurrence. Clinical Course: Patient received Other medication in 2weeks.No covid prior vaccination. After post vaccination covid tested positive.Covid test type post vaccination Nasal Swab, covid test name post vaccination PCR and binaxNow numerous times, covid test result Negative.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Erythema Multiforme and the role of suspect drug cannot be ruled out. The case will be reassessed once new information is available.
headache; received all "6 doses" of the Pfizer COVID 19 vaccine, Grey cap, already diluted vial/She confirmed the patient received the full vial as the dose administered and not just 0.3mL; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 17 year-old male patient received bnt162b2 (COMIRNATY), administration date 11Jan2022 (Batch/Lot number: unknown) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, Manufacturer Unknown), for Covid-19 Immunization. The following information was reported: OVERDOSE (non-serious) with onset 11Jan2022, outcome "unknown", described as "received all "6 doses" of the Pfizer COVID 19 vaccine, Grey cap, already diluted vial/She confirmed the patient received the full vial as the dose administered and not just 0.3mL"; HEADACHE (non-serious) with onset 12Jan2022, outcome "unknown", described as "headache". The event "received all "6 doses" of the pfizer covid 19 vaccine, grey cap, already diluted vial/she confirmed the patient received the full vial as the dose administered and not just 0.3ml" was evaluated at the emergency room visit.  Additional information: The patient believed he got the entire vial of the Grey Cap Covid Vaccine for his dose. The nurse that administered the vaccine made a mistake and drew up the entire vial and administered it to the patient. Pharmacy usually drew it up and sent the prepared syringes to the doctor's office, but this time the doctor's office had the vials and filled the syringe themselves and made the dosage error. The patient reported a headache the next day but no temperature changes or GI changes were there.  Follow-up (04Feb2022): New information from a contactable Pharmacist included: vaccination facility type , new event headache added, suspect drug detail (dose: 3). Event off-label use was deleted as booster is approved for grey cap vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Major flare up of Trigeminal Neuralgia, lasting two+ weeks more major than ever before. Sharp electrical shock-like pains constantly through the day and night. Unable to eat/drink/talk/work. 10lbs weight loss in 10 days. 6/20 Increased dose of carbamazepine did not improve. 6/23; high dose steroid injection followed by 7 day course of 20mg per day of prednisone. 17 days post injection improvement is 4 on a scale of 1-10 with 10 being 100% recovered. Advised to add gabapentin 100 mg 3 x per day.
15-20 minutes after injection, my left arm and the left side of my face went numb. Numbness intensified over the next 2-3 hours then subsided. Lack of taste was also noticed. The following day I woke up with tingling and numbness in my left jaw and slight drooping of left eye and left corner of mouth.
Per safety officer to this writer: Pt received 2nd dose of Pfizer. Pt in post observation. Pt called clinicians over. Pt found hyperventilating, dizzy and passed out in chair. Pt placed in Trendelenburg position. Clinicians administer care until AID arrived. Pt appeared pale and slowly became alert to answer AIDs questions. At 3:20 pm, Pt instructed by AID to sit up and given juice. Pt at baseline and states no relevant hx to passing out and no adverse reactions to first dose. AID cleared Pt to drive home at 3:27pm. Pt A+Ox3. Able to stand and walk with no complaints. At baseline. Time duration from onset to clear=14 min. Encouraged PT to f/u with PCP.   VS at 3:16pm BP 190/58 HR 54 O2 sat 100% on RA  VS 3:26pm  BP 110/palp HR 66 O2 sat 100% on RA BG 126
On 01/01/2023, I started having headaches on the right side only. It happened every day in January but four. I went to see a doctor in February, I took Indomethacin three times a day for two weeks. I have a neurology appointment tomorrow. They are still ongoing. I have a history of migraines.
rash started couple hr p/vax given;first few lesions on trunk;yesterday more diffuse this AM better but now w/flair;rx DPH;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 29Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 17May2022 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Atrial Fibrillation" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: Report about Covid treatment: Yes. If vaccine received: Yes.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I had pain and pressure immediately after injection, within two hours it was 10/10 pain. I went  to the ER. I was given  300mg of   Gabapentin  with no relief.  I was unable to work fo the next 5 days, and continued to have 8/10 pain at rest and loss of range of motion. Now 16 days post injection I continue to have resting pain and limited range of motion. My primary doctor scheduled me for a MRI.
Fever; Heart Palpitations; Dizziness; Nausea; This case was reported by a consumer via call center representative and described the occurrence of fever in a 58-year-old female patient who received Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 1st dose of Hepatitis B vaccine. On an unknown date, several days after receiving Hepatitis B vaccine, the patient experienced fever, palpitation, dizziness and nausea. On an unknown date, the outcome of the fever, palpitation, dizziness and nausea were recovered/resolved.   It was unknown if the reporter considered the fever, palpitation, dizziness and nausea to be related to Hepatitis B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient had received first dose of Hepatitis B vaccine about 5-6 years (2015 or 2016) ago. She experienced dizziness, fever, nausea, and heart palpitations after few days. The patient did not have any details about the vaccine, she got recovered. The reporter consented to follow up. For tolerance to 2nd dose, refer case US2021072888.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021072888:same gender, same country, same suspect
Edema, erythema, pain, limited ROM in injected arm. Also with dizziness. Also with low grade fever. Treated with prednisone.
no adverse event; a 15-month old patient was inadvertently administered PROQUAD instead of MMR-II.  Patient then proceeded to receive VARIVAX and HAVRIX concomitantly.  Confirmed that no symptomatic adv; This spontaneous report was received from a nurse and refers to a 15-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 27-JUL-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) injection, 0.5 milliliter once (lot #W024980, has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date: 05-FEB-2024)(strength, and route of administration were not provided). The patient was inadvertently administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-RII) (Wrong product administered). Then the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter once, (lot #W006412, has been verified to be a valid lot number for vaccinated with varicella virus vaccine live (oka/merck), expiration date: 23-FEB-2024) (strength, and route of administration were not provided). The patient also received hepatitis a vaccine inact (HAVRIX), 0.5 milliliter once, (lot # 2YZ9B, expiration date: 07-DEC-2023) (strength, formulation, and route of administration were not provided). All the vaccines were administered for prophylaxis. No additional adverse events were reported.
Pt recvd 1 dose of Engerix-B & 4 wks p/1st dose had elevated liver function tests (enzymes), abdominal pain & nausea; pt was treated w/analgesics & antiemetics; Reporting MD stated pt feels better, but still checking;
THERE WAS NO REPORTED ADVERSE REACTION. SPOKE WITH PATIENT'S GUARDIAN AND CONFIRMED WITH HIM THIS WAS PATIENT'S AGE AND INFORMED HIM THAT PATIENT WAS GIVEN VACCINE 4 DAYS BEFORE PATIENT WOULD BE QUALIFIED FOR THE VACCINE (AGE 12). PATIENT'S GUARDIAN SAYS THEY DID NOT EXPERIENCE ANY SYMPTOMS BACK THEN AND I INFORMED HIM THAT HE COULD REACH OUT TO ME IF ANY FURTHER QUESTIONS OR CONCERNS IN THE FUTURE. 10/29/21
Received influenza vaccine (Fluad QIV PFS HIGH DOSE) and PCV 20 vaccine on 11/28/22. Approximately 1-2 weeks after vaccines, developed numbness/tingling in bilateral toes and progressive ascending sensory loss. Also developed SOB and difficulty ambulating. Hospitalized and seen by neurology who dx'd GBS suspected 2/2 flu vaccine. Treated with IVIG
I have experienced a fluttering in my chest and some slight dizziness over the past year or so; I have experienced a fluttering in my chest and some slight dizziness over the past year or so; hunger; dehydration; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Jun2022 at 15:30 as dose 4 (booster), single (Lot number: FN2908) at the age of 66 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot Number: EN6196; , Anatomical site: Arm Left; vaccine administration Time: 12:00 AM), administration date: 02Mar2021, when the patient was 65-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot No: EN6203, Anatomical site: Arm Left; Vaccine Administration Time: 08:30 AM), administration date: 24Mar2021, when the patient was 65-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; , Lot Number: FF2590; Anatomical site: Arm Left, Vaccine Administration Time: 09:15 AM), administration date: 09Nov2021, when the patient was 65-year-old, for COVID-19 Immunization. The following information was reported: CARDIAC FLUTTER (medically significant), DIZZINESS (non-serious) all with onset 2022, outcome "unknown" and all described as "I have experienced a fluttering in my chest and some slight dizziness over the past year or so"; DEHYDRATION (non-serious) with onset 2022, outcome "unknown"; HUNGER (non-serious) with onset 2022, outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Dec2022) Negative.  Additional Information: It was reported that the patient had experienced a fluttering in chest and some slight dizziness over the past year or so, which patient  had attributed to hunger and dehydration . The patient had mentioned this to doctor at yearly physical in Oct. The patient was to monitor and make a return visit should they become more prevalent.  The patient did not receive other vaccines within four weeks prior to COVID vaccine. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201391908 same patient/drug, different dose/event;
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included nerve pain. On 31st May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 31st May 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on unknown arm. The patient experienced mild arm pain. The reporter consented to follow up. For tolerance after 2nd dose refer case US2018196936.
Patient did not have an adverse event.  This was an administration error. The patient showed up to the pharmacy 14 days after his first dose to receive his second dose. Due to extremely long lines for patients waiting for the vaccine, the person entering the information did not notice that he was requesting it early. When I ,the pharmacist reviewed the information, I noticed he was too early for his second dose. I went to tell the immunizing intern to ask the patient to come back at a later date. The intern then informed me that they were working fast to clear the line and had already given the patient the immunization before I could review the information
Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was sister-in-law of the reporter. The age at vaccination was not reported. The patient went to the doctors and got the shingles shot and the next day, she got the shingles. The patient asked her doctor about why she got the shingles because shingles was the reason that she went and got the vaccine shot and the doctor communicated that there was a little bit of Shingles in the vaccine.
pt recv vax & exp a neg varicella zoster virus antibody titer following 3rd dose of vax;no further details were provided;
The night after the second dose of the pfizer, I was sick with flu-like symptoms, a headache, a very sore arm, hot flashes and sweating. Two days later, I got an itchy and sore rash at the injection site, and I am still sweating alot, with a mild headache
Injection site pain deep in arm , stillsore to touch, no external reaction, BUT,  pain has spead  & accelerated to whole r arm, chest, shoulder, clavicle & scapula , with hand pain & numbness. Stabbing pain over deltoid inj site. Sleeping impossible- pain unresolved by medication.i cannot lie down, even when sitting, site hurts to touch.
MD inject flu vax into a nodule on the hand of a pt w/rheumatoid arthritis;pt exp inj site pain;Medical affairs note: this is an unlabelled use of this vaccine;
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 80-year-old male patient who received SHINGRIX (batch number HG4P3, expiry date 13th July 2020). On 17th May 2018, the patient received the 1st dose of SHINGRIX. In May 2018, less than a month after receiving SHINGRIX, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were recovering/resolving. It was unknown if the reporter considered the injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left deltoid. The health care professional reported that the patient experienced redness and soreness at injection site after receiving initial dose of SHINGRIX. The pain subsided after a few days however redness persisted. No treatment had been received. The patient was currently recovering with no further reports of incident regarding the event.
single unprovoked seizure out of sleep on the am of 10/16/21. no history of seizure.
Allergic (anaphylactoid) reaction resulting in acute shortness of breath with wheezing occuring within 5 to 10 minutes post injection, light-headedness resulting in loss of balance and falling. Treated with methylprednisolone IV, famotidine IV, Anzemet IV, diphenhydramine IV and albuterol/ipratropium inhalation treatments x4.
Diarrhea; throwing up; Small fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever). At the time of the report, DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
Redness, swelling pt. waited 10 to 15 min no reaction. VIS was not given.
Soreness at base of skull, neck, and shoulders radiating down arms. Extreme lethargy. Persistent headache. Pain and lethargy has not lessened in 5 days. Fever now at injection site. Chronic headache.
States severe pain started in L shoulder, elbow , wrist and collar bone 12 hours afterModerna injection. Was seen by her pmd. spoke with Pt today states she still has pain in these areas but it has decreased some.
Employee began to feel symptomatic approximately 6 hours post vaccine. Employee felt pain at injection site on the day of vaccine. Next day Employee began to feel warmth, swelling, fatigue, headache, and redness at injection site which continues to this day. Employee has applied to ice to injection site which provides little relief and has taken ibuprofen.
Began with waking to chills and incredible urge to pee.  Emptying bladder and urinating were very painful accompanied by pink tinge.  The "chills" were incredibly violent and by body was contracting involuntarily in to the fetal position, coming in waves every few seconds.  Chills lasted 3 hours.  Fever came on just after chills started. The fever of 101.9 lasted with the chills then I had a low grade fever of 99.1, until about 4pm on 12/30/20.  Every joint in my body felt like they were on fire for about an hour, and then the pain moved to my spine.  Tingling all over my body lasted 2 days (felt like when your foot falls asleep and is waking up).  2 weeks after vaccine, face tingling and chin numbness, and still continues, as does the painful bladder and urnination
Two hours after receiving Sanofi P influenza vaccine Lot # UJ210AA, I developed cough with tightness and scratchiness in throat. Then developed hives and swelling to neck with worsening cough. Remained alert, however experienced dizziness and vision changes (haziness). Symptoms progressed to having difficulty breathing, which required injection of EpiPen. Was transported to the ER via ambulance and remained inpatient for 24 hour observation.
Reported intense body pain to the ribs and hips. GI upset including nausea and diarrhea.Fever 100.2F
TD toxoid were injected instead of TB under skin.  A 7in x 4.5 in swollen reddened area with blisters centrally located was developed on my arm.